About

I am an award-winning writer, editor, photographer and designer with more than 30 years of experience in the media. After studying at the University of Leeds, then London and Anglia HEC, I moved to Canada in the 1980s and started out on the radio while also writing for various music and sports publications, and doing freelance photography. I then edited some magazines before working at a science organization, doing communications and editing publications in a programming language called LaTeX that was challenging but exciting.

Following that, I edited a newspaper, spent some time in the US, and then moved back to the UK where I edited a food B2B publication.
I’ve written, and taken photographs for, hundreds of publications around the world, as well as for books, album covers, DVDs, and shot coverage for documentaries. I’ve edited books, written nine of my own, and done redesigns for several publications. And now I’m writing about biotech, as well as creating videos and a weekly podcast.

I’ve done other things, like running an aquarium, teaching photography and drumming (not at the same time), and running football (soccer) refereeing courses.

In what spare time I have, I love spending time with my wife, son and dog, challenging hikes up the Scottish hills (and down again), playing and writing music, watching baseball and soccer, and collecting memorabilia and autographs.

Articles by Jim Cornall

Researchers’ mutation discovery offers new Alzheimer’s hope

New menopause drug gets FDA approval

Alzheimer’s drugs could result from immune brain cell discovery

DiogenX raises €27.5M for “breakthrough” diabetes treatment

Achilles Therapeutics’ new platform identifies most potent T-cell antigens

Cell and gene therapy company NewBiologix exits stealth with $50M

ADVERTISEMENT

5 highlights at first Genomics and Precision Medicine Expo

Scientists create first CRISPR-based drug candidate targeting the microbiome

Gilead boosts oncology pipeline with XinThera acquisition

Gene & cell therapy manufacturer Ascend launches with more than $130M

Ultra-long protein fibrils could help with early Alzheimer’s diagnosis

ADVERTISEMENT